We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ACW market cap is 53.52M. The company's latest EPS is AUD -0.0056 and P/E is -3.57.
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 3.52M | 1.98M | 3.64M | 4.89M | 9.93M |
Operating Income | -5.4M | -3.92M | -9.53M | -10.99M | -13.26M |
Net Income | -5.33M | -3.92M | -9.5M | -10.75M | -13.04M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 11.94M | 18.38M | 23.31M | 15.21M | 21.31M |
Total Liabilities | 1.05M | 920k | 1.57M | 1.8M | 1.62M |
Total Equity | 10.89M | 17.46M | 21.74M | 13.41M | 19.7M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -2.86M | -1.72M | -9.52M | -8.7M | -16.95M |
Investing | -23k | -6k | -3k | -37k | -8k |
Financing | 282k | 10.11M | 12.42M | 825k | 17.95M |
Market Cap | 53.52M |
Price to Earnings Ratio | -3.57 |
Price to Sales Ratio | 4.65 |
Price to Cash Ratio | 4.88 |
Price to Book Ratio | 2.36 |
Dividend Yield | - |
Shares Outstanding | 2.33B |
Average Volume (1 week) | 3.02M |
Average Volume (1 Month) | 4.53M |
52 Week Change | 21.05% |
52 Week High | 0.099 |
52 Week Low | 0.018 |
Spread (Intraday) | 0 (4.17%) |
Company Name | Actinogen Medical Limited |
Address |
level 9 sydney, new south wales 2000 |
Website | https://www.actinogen.com.au |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions